PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Diaverum Renal Care Center, 14469, Potsdam, Germany.\', \'Abbott Infectious Disease Research, Chicago, IL, 60064-3500, USA.\', \'Brandenburg Medical School Theodor Fontane, 16816, Neuruppin, Germany.\', \'Faculty of Health Sciences Brandenburg, 14469, Potsdam, Germany.\', \'Institute of Integrated Health Care Systems Research & Social Medicine, Otto-von-Guericke-University Magdeburg, 39120, Magdeburg, Germany.\', \'Department of Cardiology, Brandenburg Heart Center, Immanuel Hospital, 16321, Bernau, Germany.\', \'Diaverum AB, 21532, Malmö, Sweden.\', \'Division of Renal Medicine, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, 17177, Stockholm, Sweden.\', \'Cardiovascular Research and Development Unit, Faculty of Medicine, 4200-319, Porto, Portugal.\', \'Diaverum Renal Care Center, 14469, Potsdam, Germany. michael.haase@diaverum.com.\', \'Diaverum AB, 21532, Malmö, Sweden. michael.haase@diaverum.com.\', \'Medical Faculty, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany. michael.haase@diaverum.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40620-021-01076-0
?:hasPublicationType
?:journal
  • Journal of nephrology
is ?:pmid of
?:pmid
?:pmid
  • 34050904
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.003
?:rankingScore_hIndex
  • 62
?:title
  • Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all